Literature DB >> 7640519

Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load.

C Scheibenbogen1, T Möhler, J Haefele, W Hunstein, U Keilholz.   

Abstract

It was recently demonstrated that IL-8 is produced by melanoma cell lines and acts as an essential autocrine growth factor. We studied the constitutive production of IL-8 by melanoma cell lines and the serum concentrations in patients with metastatic melanoma. All of 10 melanoma cell lines investigated constitutively produced IL-8 (mean 315 +/- 58 pg/10(5) cells per 24 h. IL-8 was detectable (mean 159 +/- 13.1 pg/ml) in the serum of 21 out of 56 patients by an enzyme-linked immunosorbent assay (ELISA; detection limit < 100 pg/ml). There was a significant correlation with tumour load, whereas no correlation with metastatic sites was found. No increased IL-8 levels were seen in healthy controls or patients with metastatic renal cell carcinoma. These results suggest that IL-8 is constitutively produced by melanoma cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640519     DOI: 10.1097/00008390-199506000-00006

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  30 in total

1.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

Authors:  M Luca; S Huang; J E Gershenwald; R K Singh; R Reich; M Bar-Eli
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion.

Authors:  Shile Liang; Margaret J Slattery; Cheng Dong
Journal:  Exp Cell Res       Date:  2005-09-09       Impact factor: 3.905

Review 3.  Chemokines in tumor angiogenesis and metastasis.

Authors:  Seema Singh; Anguraj Sadanandam; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

4.  Aryltriflates as a Neglected Moiety in Medicinal Chemistry: A Case Study from a Lead Optimization of CXCL8 Inhibitors.

Authors:  Alessio Moriconi; Chiara Bigogno; Gianluca Bianchini; Antonio Caligiuri; Anna Resconi; Massimo G Dondio; Gaetano D'Anniballe; Marcello Allegretti
Journal:  ACS Med Chem Lett       Date:  2011-08-07       Impact factor: 4.345

5.  Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth.

Authors:  Dandan Li; Youyu Zhang; Kun Liu; Yujie Zhao; Beibei Xu; Liang Xu; Li Tan; Yuan Tian; Cunxi Li; Wenqing Zhang; Hanwei Cao; Yan-Yan Zhan; Tianhui Hu
Journal:  Lab Invest       Date:  2017-07-31       Impact factor: 5.662

6.  [Serum markers for melanoma].

Authors:  S Ugurel
Journal:  Hautarzt       Date:  2005-02       Impact factor: 0.751

7.  Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Authors:  Luca Szalontay; Andrew V Schally; Petra Popovics; Irving Vidaurre; Awtar Krishan; Marta Zarandi; Ren-Zhi Cai; Anna Klukovits; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.

Authors:  Suyun Huang; Lisa Mills; Badar Mian; Carmen Tellez; Marya McCarty; X-D Yang; Jean M Gudas; Menashe Bar-Eli
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

9.  Thrombomodulin modulates cell migration in human melanoma cell lines.

Authors:  Andreia da Silva de Oliveira; Likiu Yang; Juliana Echevarria-Lima; Robson Q Monteiro; Alireza R Rezaie
Journal:  Melanoma Res       Date:  2014-02       Impact factor: 3.599

10.  p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism.

Authors:  Adrian W O'Sullivan; Jiang H Wang; Henry P Redmond
Journal:  World J Surg Oncol       Date:  2009-11-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.